Overview

This trial is active, not recruiting.

Condition attention deficit disorder with hyperactivity
Treatments cognitive behavioral group treatment, social support problem-solving group treatment
Sponsor National Institute of Mental Health (NIMH)
Start date May 2005
End date December 2008
Trial size 84 participants
Trial identifier NCT00278473, DATR A2-AIR, R34 MH71721

Summary

This study will determine the effectiveness of group cognitive-behavioral therapy as compared to a problem-solving social support group in treating problems of time management, organization, and planning in adults with attention deficit hyperactivity disorder (ADHD).

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking double blind (subject, outcomes assessor)
Primary purpose treatment
Arm
(Experimental)
Cognitive behavioral group
cognitive behavioral group treatment
Cognitive behavioral therapy focuses on changing patterns of thinking and behavior. Each group consists of 6 to 8 members and sessions are led by a psychologist.
(Active Comparator)
Social support problem-solving group
social support problem-solving group treatment
Social support problem-solving focuses on general support, problem solving, and information sharing. Each group consists of 6 to 8 members and sessions are led by a psychologist.

Primary Outcomes

Measure
Time management, organization and planning skills
time frame: Measured at Weeks 6 and 12 and Months 3 and 6 post-treatment
ADHD symptoms
time frame: Measured at Weeks 6 and 12 and Months 3 and 6 post-treatment

Secondary Outcomes

Measure
Depression symptoms
time frame: Measured at Weeks 6 and 12 and Months 3 and 6 post-treatment
Anxiety
time frame: Measured at Weeks 6 and 12 and Months 3 and 6 post-treatment
Self-esteem
time frame: Measured at Weeks 6 and 12 and Months 3 and 6 post-treatment

Eligibility Criteria

Male or female participants from 18 years up to 65 years old.

Inclusion Criteria: - Suspected of having or have been diagnosed with ADHD - May potentially benefit from the ADHD group treatment Exclusion Criteria: - Any overt cognitive disability (e.g., Alzheimer's disease, mental retardation) - Deemed not to potentially benefit from the proposed ADHD group treatment

Additional Information

Official title Treatment of Meta-Cognitive Deficits in Adults With ADHD
Principal investigator Mary V. Solanto, PhD
Description ADHD is a chronic neurobiological condition that affects people of all ages, genders, and races. Symptoms of ADHD may include, but are not limited to, the following: poor attention span; physical restlessness or hyperactivity; excessive impulsivity; chronic procrastination; frequently losing things; poor organization, planning, and time management skills; and excessive forgetfulness. Not every person with ADHD exhibits all of these symptoms, and the severity of the disorder can range from mild to severe. While there is no cure for ADHD, the condition can be managed with an accurate diagnosis and proper treatment. Left untreated, individuals with ADHD may experience significant impairment in social, emotional, occupational, and academic functioning. Stimulant and non-stimulant medications are usually effective in alleviating symptoms of ADHD in adults. However, some research suggests that medications may not effectively treat self-management functioning problems and that as many as one-third of adults with ADHD have inadequate responses to medication treatment. Additional research on the benefits of psychosocial treatments for ADHD in adults is needed. This study will determine the effectiveness of group cognitive-behavioral therapy as compared to a problem-solving social support group in treating problems of time management, organization, and planning in adults with ADHD. Individuals interested in participating in this study will first undergo an assessment of their eligibility for inclusion in the study. The assessment will last approximately 6 hours, but can be broken up into as many as 4 separate visits. Eligible participants will be randomly assigned to either receive group cognitive-behavioral therapy or join a problem-solving social support group. Both groups will meet once a week for 12 weeks. Each session will last roughly 2 hours and will focus on building time management, organizational, and planning skills. Time management, planning, and organizational skill levels will be assessed at the treatment mid-point, immediately following the intervention, and at 3 and 6 months following the treatment. Self-esteem and symptoms of depression and anxiety will also be measured at these visits.
Trial information was received from ClinicalTrials.gov and was last updated in December 2008.
Information provided to ClinicalTrials.gov by National Institute of Mental Health (NIMH).